3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Conditions
Polycystic Ovary Syndrome
14
Breast Neoplasms
11
Prostatic Neoplasms
9
Obesity
7
Insulin Resistance
6
Carcinoma, Non-Small-Cell Lung
5
Lung Neoplasms
4
Colorectal Neoplasms
4
Motor Activity
3
Adenocarcinoma of Lung
3
Squamous Cell Carcinoma of Head and Neck
2
Pancreatic Neoplasms
2
Neoplasms
2
Menstruation Disturbances
2
Lymphoma, Large B-Cell, Diffuse
2
Head and Neck Neoplasms
2
Endometrial Neoplasms
2
Diabetes Mellitus
2
Weight Loss
1
Urothelial Cancer
1
Thyroid Diseases
1
Thoracic Neoplasms
1
Smoldering Multiple Myeloma
1
Rectal Neoplasms
1
Prediabetic State
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pleural Effusion, Malignant
1
Overweight
1
Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
1
Non-alcoholic Fatty Liver Disease
1
Interventions
fludarabine phosphate
23
Cyclophosphamide
23
Whole-Body Irradiation
20
Mycophenolic Acid
17
Peripheral Blood Stem Cell Transplantation
15
Busulfan
14
Cyclosporine
12
Tacrolimus
10
Melphalan
10
Antilymphocyte Serum
9
Cord Blood Stem Cell Transplantation
7
Rituximab
6
Radiotherapy
6
Methotrexate
6
Filgrastim
6
Etoposide
6
fludarabine
5
Methylprednisolone
5
Granulocyte Colony-Stimulating Factor
4
Vincristine
3
Thiotepa
3
Sirolimus
3
Prednisone
3
Methylprednisolone Hemisuccinate
3
Methylprednisolone Acetate
3
Doxorubicin
3
Cytarabine
3
Carboplatin
3
Alemtuzumab
3
thymoglobulin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Dendritic Cell Sarcoma, Interdigitating
×
Metformin
×
Clear all
NCT02531308
2022-09-28
DLBCL
Rush University Medical Center
Phase 2
Terminated
5 enrolled
5 charts